Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Ito

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Journal of Medical Virology|December 16, 2011
Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccineAkira Ainai, Shin-Ichi Tamura, Tadaki Suzuki, et al.
Internal Medicine (Tokyo, Japan)|August 21, 2022
Importance of the Multimodality Evaluation of a Double-chambered Right Ventricle for Surgical Indications on Admission for Acute Myocardial InfarctionShuhei Aoki, Hiroyuki Takaoka, Ryo Ito, et al.
Journal of Medicinal Chemistry|March 21, 2012
Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetesSatoshi Mikami, Shuji Kitamura, Nobuyuki Negoro, et al.
Cancers|July 27, 2022
The Safety and Clinical Validity of Endoscopic Submucosal Dissection for Early Gastric Cancer in Patients Aged More Than 85 YearsTakaaki Yoshikawa, Atsushi Yamauchi, Ryuhei Hamasaki, et al.
Plos One|August 12, 2017
Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressureDai Suzuki, Akiko Saito-Hakoda, Ryo Ito, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2019
SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and ObesityHikaru Ueno, Ryo Ito, Shin-Ichi Abe, et al.
Journal of Medicinal Chemistry|January 17, 2012
Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonistsNobuyuki Negoro, Shinobu Sasaki, Masahiro Ito, et al.
Microbiology and Immunology|January 21, 2020
Human immune responses elicited by an intranasal inactivated H5 influenza vaccineAkira Ainai, Elly van Riet, Ryo Ito, et al.
Open Biology|April 10, 2025
Correction to: 'Unravelling nicotinic receptor and ligand features underlying neonicotinoid knockdown actions on the malaria vector mosquito <i>Anopheles gambiae</i>' (2024), by Ito <i>et al.</i>Ryo Ito, Masaki Kamiya, Koichi Takayama, et al.
Endoscopy International Open|June 29, 2026
Temporary Interruption versus Continuation of Non-aspirin, Non-P2Y12 Antiplatelet Monotherapy for Delayed Post-polypectomy BleedingYutaka Okagawa, Masanori Sato, Masahiro Hirakawa, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Journal of Medical Virology|December 16, 2011
Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccineAkira Ainai, Shin-Ichi Tamura, Tadaki Suzuki, et al.
Internal Medicine (Tokyo, Japan)|August 21, 2022
Importance of the Multimodality Evaluation of a Double-chambered Right Ventricle for Surgical Indications on Admission for Acute Myocardial InfarctionShuhei Aoki, Hiroyuki Takaoka, Ryo Ito, et al.
Journal of Medicinal Chemistry|March 21, 2012
Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetesSatoshi Mikami, Shuji Kitamura, Nobuyuki Negoro, et al.
Cancers|July 27, 2022
The Safety and Clinical Validity of Endoscopic Submucosal Dissection for Early Gastric Cancer in Patients Aged More Than 85 YearsTakaaki Yoshikawa, Atsushi Yamauchi, Ryuhei Hamasaki, et al.
Plos One|August 12, 2017
Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressureDai Suzuki, Akiko Saito-Hakoda, Ryo Ito, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2019
SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and ObesityHikaru Ueno, Ryo Ito, Shin-Ichi Abe, et al.
Journal of Medicinal Chemistry|January 17, 2012
Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonistsNobuyuki Negoro, Shinobu Sasaki, Masahiro Ito, et al.
Microbiology and Immunology|January 21, 2020
Human immune responses elicited by an intranasal inactivated H5 influenza vaccineAkira Ainai, Elly van Riet, Ryo Ito, et al.
Open Biology|April 10, 2025
Correction to: 'Unravelling nicotinic receptor and ligand features underlying neonicotinoid knockdown actions on the malaria vector mosquito <i>Anopheles gambiae</i>' (2024), by Ito <i>et al.</i>Ryo Ito, Masaki Kamiya, Koichi Takayama, et al.
Endoscopy International Open|June 29, 2026
Temporary Interruption versus Continuation of Non-aspirin, Non-P2Y12 Antiplatelet Monotherapy for Delayed Post-polypectomy BleedingYutaka Okagawa, Masanori Sato, Masahiro Hirakawa, et al.
Pageof 16